, 50:1041 | Cite as

Abciximab for thrombolysis during intracranial aneurysm coiling

  • Jan GrallaEmail author
  • Adam T. M. Rennie
  • Rufus A. Corkill
  • Shivendra T. Lalloo
  • Andrew Molyneux
  • James V. Byrne
  • Wilhem Kuker
Interventional Neuroradiology



Thrombotic events are a common and severe complication of endovascular aneurysm treatment with significant impact on patients’ outcome. This study evaluates risk factors for thrombus formation and assesses the efficacy and safety of abciximab for clot dissolution.

Materials and methods

All patients treated with abciximab during (41 patients) or shortly after (22 patients) intracranial aneurysm coil embolisation were retrieved from the institutional database (2000 to 2007, 1,250 patients). Sixty-three patients (mean age, 55.3 years, ±12.8) had received either intra-arterial or intravenous abciximab. Risk factors for clot formation were assessed and the angiographic and clinical outcome evaluated.


No aneurysm rupture occurred during or after abciximab application. The intra-procedural rate of total recanalisation was 68.3%. Thromboembolic complications were frequently found in aneurysms of the Acom complex and of the basilar artery, whilst internal carotid artery aneurysms were underrepresented. Two patients died of treatment-related intracranial haemorrhages into preexisting cerebral infarcts. Two patients developed a symptomatic groin haematoma.


Abciximab is efficacious and safe for thrombolysis during and after endovascular intracranial aneurysm treatment in the absence of preexisting ischaemic stroke.


Abciximab Aneurysm Endovascular treatment Thromboembolic complication 


Conflict of interest statement

We declare that we have no conflict of interest.


  1. 1.
    Mounayer C, Piotin M, Baldi S, Spelle L, Moret J (2003) Intraarterial administration of Abciximab for thromboembolic events occurring during aneurysm coil placement. AJNR Am J Neuroradiol 24(10):2039–2043PubMedGoogle Scholar
  2. 2.
    Eskridge JM, Song JK (1998) Endovascular embolization of 150 basilar tip aneurysms with Guglielmi detachable coils: results of the Food and Drug Administration Multicenter Clinical Trial. J Neurosurg 89(1):81–86PubMedCrossRefGoogle Scholar
  3. 3.
    van Rooij WJ, Sluzewski M, Beute GN, Nijssen PC (2006) Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. AJNR Am J Neuroradiol 27(7):1498–1501PubMedGoogle Scholar
  4. 4.
    Henkes H, Fischer S, Weber W, Miloslavski E, Felber S, Brew S et al (2004) Endovascular coil occlusion of 1811 intracranial aneurysms: early angiographic and clinical results. Neurosurgery 54(2):268–280. doi: 10.1227/01.NEU.0000103221.16671.F0 PubMedCrossRefGoogle Scholar
  5. 5.
    van Rooij WJ, Sluzewski M, Beute GN, Nijssen PC (2006) Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. AJNR Am J Neuroradiol 27(7):1498–1501PubMedGoogle Scholar
  6. 6.
    Grunwald IQ, Papanagiotou P, Politi M, Struffert T, Roth C, Reith W (2006) Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events. Neurosurgery 58(4):612–618. doi: 10.1227/01.NEU.0000204101.00996.D9 PubMedCrossRefGoogle Scholar
  7. 7.
    Workman MJ, Cloft HJ, Tong FC, Dion JE, Jensen ME, Marx WF et al (2002) Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol 23(9):1568–1576PubMedGoogle Scholar
  8. 8.
    Vinuela F, Duckwiler G, Mawad M (1997) Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 86(3):475–482PubMedGoogle Scholar
  9. 9.
    Velat GJ, Burry MV, Eskioglu E, Dettorre RR, Firment CS, Mericle RA (2006) The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol 65(4):352–358 discussion. doi: 10.1016/j.surneu.2005.08.024 PubMedCrossRefGoogle Scholar
  10. 10.
    Cronqvist M, Pierot L, Boulin A, Cognard C, Castaings L, Moret J (1998) Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: a comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol 19(1):157–165PubMedGoogle Scholar
  11. 11.
    Bruening R, Mueller-Schunk S, Morhard D, Seelos KC, Brueckmann H, Schmid-Elsaesser R et al (2006) Intraprocedural thrombus formation during coil placement in ruptured intracranial aneurysms: treatment with systemic application of the glycoprotein IIb/IIIa antagonist tirofiban. AJNR Am J Neuroradiol 27(6):1326–1331PubMedGoogle Scholar
  12. 12.
    Yi HJ, Gupta R, Jovin TG, Tayal A, Genevro J, Gologorsky Y et al (2006) Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol 27(9):1856–1860PubMedGoogle Scholar
  13. 13.
    Katsaridis V, Papagiannaki C, Skoulios N, Achoulias I, Peios D (2008) Local intra-arterial eptifibatide for intraoperative vessel thrombosis during aneurysm coiling. AJNR Am J Neuroradiol 29:1414–1417PubMedCrossRefGoogle Scholar
  14. 14.
    Cloft HJ, Samuels OB, Tong FC, Dion JE (2001) Use of abciximab for mediation of thromboembolic complications of endovascular therapy. AJNR Am J Neuroradiol 22(9):1764–1767PubMedGoogle Scholar
  15. 15.
    Bendok BR, Padalino DJ, Levy EI, Qureshi AI, Guterman LR, Hopkins LN (2004) Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization: case report and literature review. Surg Neurol 62(4):304–311. doi: 10.1016/j.surneu.2003.10.045 PubMedCrossRefGoogle Scholar
  16. 16.
    Ng PP, Phatouros CC, Khangure MS (2001) Use of glycoprotein IIb–IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol 22(9):1761–1763PubMedGoogle Scholar
  17. 17.
    Song JK, Niimi Y, Fernandez PM, Brisman JL, Buciuc R, Kupersmith MJ et al (2004) Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab. AJNR Am J Neuroradiol 25(7):1147–1153PubMedGoogle Scholar
  18. 18.
    Aviv RI, O'Neill R, Patel MC, Colquhoun IR (2005) Abciximab in patients with ruptured intracranial aneurysms. AJNR Am J Neuroradiol 26(7):1744–1750PubMedGoogle Scholar
  19. 19.
    van Rooij WJ, Sluzewski M, Beute GN, Nijssen PC (2006) Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. AJNR Am J Neuroradiol 27(7):1498–1501PubMedGoogle Scholar
  20. 20.
    Layton KF, Cloft HJ, Gray LA, Lewis DA, Kallmes DF (2007) Balloon-assisted coiling of intracranial aneurysms: evaluation of local thrombus formation and symptomatic thromboembolic complications. AJNR Am J Neuroradiol 28(6):1172–1175. doi: 10.3174/ajnr.A0490 PubMedCrossRefGoogle Scholar
  21. 21.
    Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA et al (2005) International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366(9488):809–817. doi: 10.1016/S0140-6736(05)67214-5 PubMedCrossRefGoogle Scholar
  22. 22.
    Mascelli MA, Lance ET, Damaraju L, Wagner CL, Weisman HF, Jordan RE (1998) Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation 97(17):1680–1688PubMedGoogle Scholar
  23. 23.
    Tcheng JE (1994) Dosing and administration of ReoPro (c7E3 Fab). J Invasive Cardiol 6(Suppl A):29A–33APubMedGoogle Scholar
  24. 24.
    Ries T, Buhk JH, Kucinski T, Goebell E, Grzyska U, Zeumer H et al (2006) Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 37(7):1816–1821. doi: 10.1161/01.STR.0000226933.44962.a6 PubMedCrossRefGoogle Scholar
  25. 25.
    Coller BS, Peerschke EI, Scudder LE, Sullivan CA (1983) A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 72(1):325–338. doi: 10.1172/JCI110973 PubMedCrossRefGoogle Scholar
  26. 26.
    Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M et al (2002) Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 33(7):1916–1919. doi: 10.1161/01.STR.0000019423.08947.43 PubMedCrossRefGoogle Scholar
  27. 27.
    Lee KY, Heo JH, Lee SI, Yoon PH (2001) Rescue treatment with abciximab in acute ischemic stroke. Neurology 56(11):1585–1587PubMedGoogle Scholar
  28. 28.
    Adams HP Jr, Effron MB, Torner J, Davalos A, Frayne J, Teal P et al (2008) Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT-II). Stroke 39(1):87–99. doi: 10.1161/STROKEAHA.106.476648 PubMedCrossRefGoogle Scholar
  29. 29.
    Blankenship JC, Hellkamp AS, Aguirre FV, Demko SL, Topol EJ, Califf RM (1998) Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Trial. Am J Cardiol 81(1):36–40. doi: 10.1016/S0002-9149(97)00796-0 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Jan Gralla
    • 1
    • 2
    Email author
  • Adam T. M. Rennie
    • 1
  • Rufus A. Corkill
    • 1
  • Shivendra T. Lalloo
    • 1
  • Andrew Molyneux
    • 1
  • James V. Byrne
    • 1
  • Wilhem Kuker
    • 1
  1. 1.Department of NeuroradiologyWest Wing, John Radcliffe HospitalOxfordUK
  2. 2.Department of NeuroradiologyInselspital-University of BernBernSwitzerland

Personalised recommendations